Reshaping Surgical Oncology after COVID-19

Friday 23 October 2020, 16:00 - 21:00 CEST
Saturday 24 October 2020, 09:00 - 13:00 CEST



Friday 23 October 2020, 16:00 - 21:00 CET

16:00 - 16:04

Welcome by the ESSO President, Tibor Kovacs, UK

16:04 - 16:05

Sponsors´ pitches

16:05 – 16:50

Impact of COVID-19 on cancer surgical care (cross-specialty session)

Chair: Tibor Kovacs, UK
Co-chair: James Howe, USA
Moderator: Delia Cortes Guiral, SP

  • COVID-19 burden in High Income Countries (HIC) and how it affected surgical care for cancer patients - Speaker: Marco Montorsi, IT

  • COVID-19 burden in Low and Middle Income Countries (LMIC) and how it affected surgical care for cancer patients - Speaker: Dr. SVS Deo, IN

  • COVIDSurg-Cancer: Improving safety of surgery for patients undergoing cancer surgery during the SARS-CoV-2 pandemic - Speaker: James Glasbey, Elizabeth Li (on behalf of the CovidSurg Collaborative)

  • The SWALIS-2020 new model to prioritize elective surgery under the COVID-19 pandemic pressure Speaker: Roberto Valente, IT

  • Open panel discussion

16:50 – 17:20

Sysmex Satellite Symposium - Discover optimised techniques for lesion localisation, sentinel node biopsy and TAD

  • Magseed® as long-term marker for target lymph nodes during neoadjuvant therapy – first experiences and perspectives – Speaker: Marc Thill, DE

  • Using Magtrace® and Magseed® to improve the care process and comfort for breast cancer patients and their treatment providers – Speaker: Maria Margarete Karsten, DE

17:20 - 18:20

Breast session: Tailoring breast cancer surgical treatments in the era of de-escalation

Chair: Isabel Teresa Rubio, SP
Co-chair: Giacomo Montagna, CH
Moderator: Emily Postma, NL

  •  Surgical de-escalation in Her2 positive breast cancer patients. The ideal subtype - Speaker: Reimer Toralf, DE

  • Techniques for excising the marked nodes after neoadjuvant treatment. Will any become the gold standard? - Speaker: Tanir M. Allweis, IL

  • Neoadjuvant chemotherapy in the era of immunotherapy: the future is bright - Speaker: Carmen Criscitiello, Milan, IT

  • Tumour-stroma ratio is associated with Miller-Payne grading system and pathological response to neoadjuvant chemotherapy in HER2-negative breast cancer - Speaker: Sophie Hagenaars, NL

  • Can machine learning be used to reduce overtreatment of the axilla in breast cancer? Results from a retrospective cohort study - Speaker: Felix Jozsa, UK

  • FaMRIsc trial shows: MRI breast screening for women with ≥20% lifetime risk is also cost-effective in Europe - Speaker: Madeleine Tilanus-Linthorst, NL

  • Open panel discussion

18:20 – 18:35

Sirius Medical Systems Satellite Workshop

  • Moderator: Jan Willem Beijer

  • Moderator: Massimiliano Malloni

18:35 – 19:20

HPB updates

Chair: Chandra Are, USA
Co-chair: Hassan Malik, UK  
Moderator: Florian Primavesi, AT

  • Current status on surgical management of Oligometastatic pancreas cancer - Speaker: Kevin Conlon, IE

  • Current landscape of MIS in HPB surgery - Speaker: Daniel Anaya, US

  • Impact of AI on HPB surgery - Speaker: Benoît Gallix, FR

  • Hepatic and extrahepatic colorectal metastases have discordant responses to chemotherapy: Pathology data from patients undergoing simultaneous resection of multiple tumor sites - Speaker: Pio Corleone, IT

  • Open panel discussion

19:20 – 19:50

Agendia Satellite Symposium

Moderator: Laura van ‘t Veer, NL

  • How does genomic profiling impact your breast cancer surgery? – Speakers: Emiel J.T. Rutgers, Isabel Teresa Rubio, SP

19:50 – 20:50

Hot Topics in the therapy of Colorectal Cancer

Chair: Geerard Beets, NL
Co-chair: Isacco Montroni, IT
Moderator: Laura Lorenzon, IT

  •  Total neoadjuvant therapy in rectal cancer - Speaker: C. J. van de Velde, NL

  •  TAMIS (Video presentation) - Speaker: Sam Atallah, USA

  •  Immunotherapy in colorectal cancer - Speaker: Myriam Chalabi, NL

  • Malignant features present in pre-treatment lateral pelvic lymph nodes in low rectal cancer predict distant metastases and survival, but not local recurrences Speaker: Hidde Kroon, AU

  • Patterns of failure and outcomes of rectal cancer patients who had a positive pathological circumferential resection margin (pCRM)  - Speaker: Swapnil Patel, IN

  • Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Limited Peritoneal Metastasis. The PSOGI International Collaborative Registry - Speaker: Alvaro Arjona, SP

  • Open panel discussion

20:50 – 20:55

 Closing remarks, Domenico D’Ugo, IT

Saturday 24 October 2020, 09:00 - 13:05 CET

09:00 - 09:05

Welcome by the ESSO President-Elect, Domenico D’Ugo, IT

09:05 – 09:50

Robotic surgery for Abdominal Cancers: How far can we go?

Chair: Han-Kwang Yang, KR
Co-Chair: Andreas Brandl, PT

  • Robotics for Gastric Cancer - Speaker: Masnori Terashima, JP

  • Robotics in lower GI - Speaker: Amjad Parvaiz, UK

  • Robotics in HPB - Speaker: Johann Pratschke, DE

  • Robotic complete mesocolic excision with central vascular ligation for right colonic tumours—technical notes and oncological outcomes compared to a propensity score-matched laparoscopic group  - Speaker: Samuel Stefan, UK

  • Open panel discussion

09:50 – 10:20

S.I.T. Symposium / IOeRT Clinical Guidelines & Applications and Groundbreaking Technological Developments

  • Introduction of IOeRT principles and current applications in surgical oncology – Speakers: Felipe Calvo Manuel, Isabel Teresa Rubio, SP, Philip Poortmans, FR

10:20 - 11:05

Upper GI session

Chair: William Allum, UK
Co-Chair: Beate Rau, DE
Moderator:  Karol Polom, PL

  • KLASS-02 for Gastric Cancer -  Speaker: Sang-Uk Han, KR

  • Complications in Upper GI surgery - Speaker: Gian Luca Baiocchi, IT

  • Trial Update - Immunotherapy - Speaker: Elizabeth Smyth, UK

  • 10-year outcome of a randomized trial comparing neoadjuvant chemoradiotherapy and surgery with surgery alone for esophageal cancer (CROSS trial) - Speaker: Ben Eyck, NL

  • Open panel discussion

11:05 – 11:35

Hologic Symposium

Moderator: Bob Martins, FR

  • Wire-free Localization for surgery of non-palpable breast lesions with LOCalizer radiofrequency identification (RFID) tags : our experience from the first 150 cases – Speaker: Robert Milligan, UK

11:35 – 12:05

Medical nutrition along the surgical oncology patient’s journey (cross specialty session)
Session supported by an unrestricted grant from ESSO corporate member Nutricia

Chair: Sergio Sandrucci, IT
Co-chair: Wim Ceelen, BE
Moderator: Yvonne Schrage, NL

  • Perioperative Nutritional Support of oncologic surgical Patients in the Age of ERAS - Speaker: Luca Nespoli, IT

  • Clinical Value of Nutritional Status in Cancer surgery: can Disease Progression and Prognosis be affected? - Speaker: Alessandro Laviano, IT

  • Open panel discussion

12:05 – 12:20


12:20 – 13:05

Impact of COVID-19 on surgical and surgical oncology education (cross-specialty session)

Chair: Domenico D’Ugo, IT
Co-chair: Douglas Tyler, USA
Moderator: Nada Santrac, SB

  • Impact of COVID-19 on educating the next generation of surgical oncologists in Low and Middle Income Countries (LMIC) - Speaker: Pankaj Kumar Garg, IN

  • Future of Surgical Oncology in the era of COVID-19 - Speaker: Douglas Tyler, USA

  • Training in Surgical Oncology during & beyond COVID19 pandemic - Speaker: Jim Khan, UK

  • Open panel discussion

13:00 – 13:05

Take home message, Domenico D’Ugo, IT